ID: ALA5268209

Max Phase: Preclinical

Molecular Formula: C20H19N3O3S

Molecular Weight: 381.46

Associated Items:

Representations

Canonical SMILES:  CN1CCN(c2ccc(/C=C3\Sc4ccccc4C3=O)cc2[N+](=O)[O-])CC1

Standard InChI:  InChI=1S/C20H19N3O3S/c1-21-8-10-22(11-9-21)16-7-6-14(12-17(16)23(25)26)13-19-20(24)15-4-2-3-5-18(15)27-19/h2-7,12-13H,8-11H2,1H3/b19-13-

Standard InChI Key:  OBKVEGSZDNHKMF-UYRXBGFRSA-N

Associated Targets(Human)

C-type lectin domain family 4 member M 115 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 381.46Molecular Weight (Monoisotopic): 381.1147AlogP: 3.68#Rotatable Bonds: 3
Polar Surface Area: 66.69Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.20CX LogP: 3.57CX LogD: 3.36
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.46Np Likeness Score: -1.62

References

1. Sethi A, Sanam S, Alvala M..  (2021)  Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.,  222  [PMID:34146913] [10.1016/j.ejmech.2021.113561]

Source